US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Dec. 23 for "RAB13 and NET1 antisense oligonucleotides to treat metastatic cancer" (Maryland Inventor)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,695, issued on Dec. 23, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"RAB13 and NET1 antisense oligonucleotides to treat metastatic cancer" was invented by Stavroula Mili (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antisense oligonucleotides (ASOs) specific for Rab13 and Net1, for example specific for a GA-rich region of the 3'-UTR. In some examples, the ASOs are modified. Methods of using these ASOs to reduce the migration of metastatic cancer cells are provided, for example as a use to treat metastatic cancer."

The pate...